Datafin

Data-driven stock analysis platform for global investors.

Sitemap
HomeScreenerValuationSector Analysis
Resources
LibraryDatafin GuideMetric MethodologyValuation MethodologiesFAQPricingWho Is Datafin?Communication
Legal
Privacy PolicyTerms of UseCookie PolicyKVKK NoticeRefund Policy
Data Sources

Financial data sourced from official regulatory filings and verified market data providers. Metrics calculated using GAAP/IFRS standards.

Disclaimer

The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

Investment decisions involve risk. Verify data independently and consult a licensed advisor when needed.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved.

Last updated: April 2026

EMBC PEER ANALYSIS

Embecta Corp — metric-by-metric comparison with peers and the industry median

EMBCEmbecta Corp

🇺🇸 USA · NASDAQ · Healthcare · Medical Instruments & Supplies

Value itDuel
PriceFinancialsPeers

Overall Profile & Returns

· Medical Instruments & Supplies

Position Within Industry

0 = weak quartile, 100 = strong quartile
ValuationProfitabilityGrowthFinancial HealthDividend
EMBCIndustry median

Scores normalize each metric against industry quartiles (p25–p75); direction is inverted for lower-is-better metrics.

Return Comparison

1-Year
Split-adjusted
EMBC-65.0%CTEC-13.4%SEYKM+49.7%ANN+4.7%
Year-to-Date (YTD)
EMBC-71.1%CTEC-6.8%SEYKM-7.8%ANN-7.7%
1-Year
Split-adjusted
EMBC-65.0%KRMD+25.1%SMTI-15.0%UTMD+23.1%OSUR+41.6%ANGO+42.2%
Year-to-Date (YTD)
EMBC-71.1%KRMD-21.0%SMTI+6.2%UTMD+24.5%OSUR+78.5%ANGO+1.8%

Key Metric Comparison

P/E

Lower is better
EMBC1.77CTEC34.07SEYKM261.41ANN23.77Median 35.66

ROE

Higher is better
EMBC—CTEC10.9%SEYKM0.7%ANN7.2%Median 2.3%

Net Margin

Higher is better
EMBC10.7%CTEC7.2%SEYKM1.3%ANN6.7%Median 3.9%

Revenue Growth

Higher is better
EMBC-3.4%CTEC6.8%SEYKM-24.8%ANN11.4%Median 6.4%

P/E

Lower is better
EMBC1.77KRMD—SMTI—UTMD20.36OSUR—ANGO—Median 35.66

ROE

Higher is better
EMBC—KRMD-13.7%SMTI-153.7%UTMD9.1%OSUR-21.2%ANGO-17.5%Median 2.3%

Net Margin

Higher is better
EMBC10.7%KRMD-5.3%SMTI-31.2%UTMD28.9%OSUR-66.4%ANGO-10.0%Median 3.9%

Revenue Growth

Higher is better
EMBC-3.4%KRMD23.3%SMTI17.4%UTMD-4.4%OSUR-30.1%ANGO10.7%Median 6.4%

All Metrics

Valuation
MetricEMBCCTECSEYKMANNInd. Median
P/E1.77●34.07261.4123.7735.66
P/B-0.32●3.931.621.633.04
EV/EBITDA4.26●11.97410.4012.3514.48
P/S0.19●2.443.461.562.85
Financial Health
MetricEMBCCTECSEYKMANNInd. Median
Current Ratio2.461.536.82●2.362.40
Debt/Equity-216.9%●100.0%0.0%46.2%34.8%
NetDebt/EBITDA3.642.33-168.37●2.101.44
Profitability
MetricEMBCCTECSEYKMANNInd. Median
Net Margin10.7%●7.2%1.3%6.7%3.9%
ROE—10.9%●0.7%7.2%2.3%
ROA10.4%●4.8%0.6%4.2%1.5%
EBITDA Margin30.9%●25.3%0.6%15.2%13.8%
Growth + Dividend
MetricEMBCCTECSEYKMANNInd. Median
Rev. Growth-3.4%6.8%-24.8%11.4%●6.4%
NI Growth114.8%●-8.0%—23.8%14.0%
Div. Yield17.9%●3.3%0.0%1.7%1.7%
Payout31.5%78.1%0.0%53.2%22.4%
Valuation
MetricEMBCKRMDSMTIUTMDOSURANGOInd. Median
P/E1.77●——20.36——35.66
P/B-0.32●12.5831.691.830.963.143.04
EV/EBITDA4.26●—30.928.17——14.48
P/S0.19●4.922.075.882.661.732.85
Financial Health
MetricEMBCKRMDSMTIUTMDOSURANGOInd. Median
Current Ratio2.462.332.2828.64●5.462.352.40
Debt/Equity-216.9%●19.9%688.1%0.2%12.9%—34.8%
NetDebt/EBITDA3.643.684.17-5.33●2.14—1.44
Profitability
MetricEMBCKRMDSMTIUTMDOSURANGOInd. Median
Net Margin10.7%-5.3%-31.2%28.9%●-66.4%-10.0%3.9%
ROE—-13.7%-153.7%9.1%●-21.2%-17.5%2.3%
ROA10.4%●-8.2%-40.5%8.8%-17.9%-11.5%1.5%
EBITDA Margin30.9%-3.4%7.7%43.6%●-56.4%-1.7%13.8%
Growth + Dividend
MetricEMBCKRMDSMTIUTMDOSURANGOInd. Median
Rev. Growth-3.4%23.3%●17.4%-4.4%-30.1%10.7%6.4%
NI Growth114.8%●——-16.3%——14.0%
Div. Yield17.9%●——1.7%——1.7%
Payout31.5%——36.5%——22.4%

The green dot marks the best value in the group given the metric direction (higher/lower is better). All metrics use trailing-twelve-month (TTM) data.

Go deeper on EMBC

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 7, 26. This content is for informational purposes only and is not investment advice.